AGL 38.48 Decreased By ▼ -0.08 (-0.21%)
AIRLINK 203.02 Decreased By ▼ -4.75 (-2.29%)
BOP 10.17 Increased By ▲ 0.11 (1.09%)
CNERGY 6.54 Decreased By ▼ -0.54 (-7.63%)
DCL 9.58 Decreased By ▼ -0.41 (-4.1%)
DFML 40.02 Decreased By ▼ -1.12 (-2.72%)
DGKC 98.08 Decreased By ▼ -5.38 (-5.2%)
FCCL 34.96 Decreased By ▼ -1.39 (-3.82%)
FFBL 86.43 Decreased By ▼ -5.16 (-5.63%)
FFL 13.90 Decreased By ▼ -0.70 (-4.79%)
HUBC 131.57 Decreased By ▼ -7.86 (-5.64%)
HUMNL 14.02 Decreased By ▼ -0.08 (-0.57%)
KEL 5.61 Decreased By ▼ -0.36 (-6.03%)
KOSM 7.27 Decreased By ▼ -0.59 (-7.51%)
MLCF 45.59 Decreased By ▼ -1.69 (-3.57%)
NBP 66.38 Decreased By ▼ -7.38 (-10.01%)
OGDC 220.76 Decreased By ▼ -1.90 (-0.85%)
PAEL 38.48 Increased By ▲ 0.37 (0.97%)
PIBTL 8.91 Decreased By ▼ -0.36 (-3.88%)
PPL 197.88 Decreased By ▼ -7.97 (-3.87%)
PRL 39.03 Decreased By ▼ -0.82 (-2.06%)
PTC 25.47 Decreased By ▼ -1.15 (-4.32%)
SEARL 103.05 Decreased By ▼ -7.19 (-6.52%)
TELE 9.02 Decreased By ▼ -0.21 (-2.28%)
TOMCL 36.41 Decreased By ▼ -1.80 (-4.71%)
TPLP 13.75 Decreased By ▼ -0.02 (-0.15%)
TREET 25.12 Decreased By ▼ -1.33 (-5.03%)
TRG 58.04 Decreased By ▼ -2.50 (-4.13%)
UNITY 33.67 Decreased By ▼ -0.47 (-1.38%)
WTL 1.71 Decreased By ▼ -0.17 (-9.04%)
BR100 11,890 Decreased By -408.8 (-3.32%)
BR30 37,357 Decreased By -1520.9 (-3.91%)
KSE100 111,070 Decreased By -3790.4 (-3.3%)
KSE30 34,909 Decreased By -1287 (-3.56%)

THE HAGUE: Dutch electronics giant Philips said Wednesday it has set aside a further 225 million euros for a recall of faulty respiratory equipment that puts users at risk of inhaling toxic foam.

The company earmarked 500 million euros ($567 million) for the issue last year, but said more money was needed because more of the devices needed to be repaired than expected.

Philips shares fell 14 percent on the Amsterdam stock exchange after the announcement.

"Patient well-being is at the heart of everything we do at Philips, and we aim to get a solution to patients as fast as possible," Philips chief executive Frans van Houten said in a statement.

The devices in question are mainly for use in the home for patients with problems such as sleep apnoea, a disorder in which breathing stops and starts.

Philips recalled them in June after announcing that users were at risk of inhaling or swallowing pieces of degraded sound-dampening foam.

Philips Q4 earnings hit by part shortages and ventilator recall

Patients risked "possible toxic and carcinogenic effects" from the foam, as well as other symptoms including headaches, the firm said last year.

Philips said it was now "increasing the field action provision by around 225 million euros, mainly due to the higher volume of devices now requiring remediation", after expanding the recall to some older models.

The firm now expects to have to repair 5.2 million devices worldwide. So far it said it had produced 1.5 million repair kits of which 700,000 have reached customers.

Philips has confirmed it is a defendant in a number of consumer class action lawsuits from users of the devices as well as some personal injury claims.

It warned on Wednesday that sales for the final quarter of 2021 are likely to be 350 million euros lower than expected at 4.9 billion euros, due to the recall and supply chain problems.

Philips was founded as a lighting firm more than 100 years ago and made its name through household appliances but in recent years has focused on healthcare.

Comments

Comments are closed.